Vanguard Group’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$318K Hold
2022
Q2
$1.08M Sell
2022
Q1
$2.41M Sell
2021
Q4
$4.79M Sell
2021
Q3
$5.83M Buy
2021
Q2
$6.95M Buy
2021
Q1
$5.44M Buy
2020
Q4
$2.56M Buy
2020
Q3
$2.56M Sell
2020
Q2
$3.39M Sell
2020
Q1
$2.44M Sell
2019
Q4
$4.53M Sell
2019
Q3
$3.1M Buy
2019
Q2
$8.84M Buy
2019
Q1
$1.75M Buy
2018
Q4
$544K Buy